Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma × Phlebotomy × CNS × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 2 CNS 1

Conditions

Brain Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Mucopolysaccharidosis I 1 Lymphoma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Esthesioneuroblastoma, Olfactory 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

Melphalan 9 Cyclophosphamide 9 Temozolomide 7 Radiotherapy 7 Filgrastim 7 Busulfan 7 Magnetic Resonance Spectroscopy 5 sargramostim 4 fludarabine 4 Rituximab 4 Psychiatric Rehabilitation 4 Methylprednisolone 4 Methotrexate 4 Flow Cytometry 4 Etoposide 4 Cytarabine 4 Alemtuzumab 4 etoposide phosphate 3 Vincristine 3 Thiotepa 3 Nivolumab 3 Granulocyte Colony-Stimulating Factor 3 Early Intervention, Educational 3 Drug Therapy 3 Dexamethasone 3 Carboplatin 3 Antilymphocyte Serum 3 fludarabine phosphate 2 aldesleukin 2 Topotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01540175 2015-07-14

IROPAST

St. Jude Children's Research Hospital

Brain Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡